Identification and quantitation of PAF from psoriatic scales.
Platelet activating factor was isolated from scales of psoriatic patients by the procedure of Bligh and Dyer and purified by silica gel thin layer chromatography. The purified PAF was digested with phospholipase C and the resulting diglyceride was derivatized into PFB ethers. The PAF-PFB ethers were analyzed using fused silica capillary chromatography-negative ion chemical ionization mass spectrometry. Different molecular species of PAF were identified by their negative ion mass spectra and by their elution time from the capillary column. All the molecular species had high abdundance (greater than 90%) of the molecular anion. 1-0-Hexadecyl-2-acetyl-GPC (16:0) was the major PAF species representing 51% of the total PAF. 17:0 and 18:1 were the next abundant species representing 15 and 16%, respectively. Several minor PAF molecular species were also present. The amount of each PAF molecular species was quantitated from 1-0-hexadecyl-2-2H3 acetyl-GPC used as the internal standard. Nanogram quantities of PAF were recovered from 100 mg of psoriatic scales. Significant amounts of lysoPAF were also present in these scales. The alkyl chain of the lysoPAF was compared with that of PAF.
Inflammation and Immunology Research Department, Lederle Laboratories, American Cyanamid Company, Pearl River, New York 10965.
C S
CS
Ramesha
N
N
Soter
W C
WC
Pickett
D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D010972:Platelet Activating Factor / Q000032:analysis*; D011565:Psoriasis / Q000378:metabolism*
D010972:Platelet Activating Factor